DELBEXVI
Live / Allowed — Publication / registration review complete (as of 23 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99457072
- Mark type
- Stylized text
- Filed
- 22 Oct 2025
- Published for opposition
- 14 Apr 2026
- Attorney of record
- Gazal Pour-Moezzi
Goods and services
- Class 005 — Pharmaceuticals: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders; biological and pharmaceutical preparations for the treatment of blood cancers, leukemia, lymphoma, and myeloma
Owner
- Nurix Therapeutics, Inc., Brisbane, CA, US
Prosecution history
- 17 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Mar 2026 — ASSIGNED TO EXAMINER
- 22 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 22 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Oct 2025 — NEW APPLICATION ENTERED